TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS Share Price
Certificat
DE000SY0UFG3
| Market Closed - Boerse Frankfurt Warrants 20:51:11 28/06/2024 BST | ||
| 11.51 EUR | +3.79% |
|
| Current month | -13.41% | ||
| 1 month | -17.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 11.04 | -0.45% |
| 27/06/24 | 11.09 | -0.98% |
| 26/06/24 | 11.2 | -0.27% |
| 25/06/24 | 11.23 | +2.46% |
| 24/06/24 | 10.96 | -4.94% |
Real-time Boerse Frankfurt Warrants
Last update June 28, 2024 at 08:51 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | 
Société Générale
|
| WKN | SY0UFG |
| ISIN | DE000SY0UFG3 |
| Date issued | 24/05/2024 |
| Strike | 591.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 13.74 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.18 € |
|---|---|
| Lowest since issue | 9.68 € |
| Spread | 0.06 € |
| Spread % | 0.52% |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
468.7
USD
Average target price
468.3
USD
Spread / Average Target
-0.10%
- Stock Market
- Certificates
- Certificat
